Suppr超能文献

持续未折叠蛋白反应参与了奥普佐米治疗慢性髓性白血病细胞死亡的诱导。

Prolonged unfolded protein reaction is involved in the induction of chronic myeloid leukemia cell death upon oprozomib treatment.

机构信息

Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Biobank, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

出版信息

Cancer Sci. 2021 Jan;112(1):133-143. doi: 10.1111/cas.14696. Epub 2020 Nov 12.

Abstract

To select the most efficient chemical to induce apoptosis in leukemia cells, a multidrug screen was applied on bone marrow mononuclear cells from chronic myeloid leukemia (CML) patients. Oprozomib (Cpd 21) was chosen for the subsequent experiments. The isobaric tags for relative and absolute quantitation (iTRAQ) was then performed to identify the responsible pathway relative to apoptosis and the results showed that endoplasmic reticulum (ER) chaperones were upregulated. Apoptosis was attributed to a joint effect of calcium leakage andPERK and IRE1α phosphorylation. The PERK branch was responsible for the first wave of cell death that occurred within 24 hours. The later wave of apoptosis was mediated by IRE1α, which transmit apoptotic signals through the ASK-JNK-BIM axis. Release of Ca2+ from ER into cytosol resulted in activation of calpain, which, in turn, cleaved caspase-12. Our data also explained the selective killing effects of oprozomib on CML cells, which relied on proteasome activity. The present study demonstrated that prolonged inhibition of proteasome to trigger unfolded protein response could be an alternative strategy for treating CML in light of tyrosine kinase inhibitors resistance.

摘要

为了筛选出诱导白血病细胞凋亡的最有效化学物质,对慢性髓性白血病(CML)患者的骨髓单核细胞进行了多药物筛选。选择 Oprozomib(CpD21)用于后续实验。然后进行等重同位素标记相对和绝对定量(iTRAQ),以确定与细胞凋亡相关的负责途径,结果表明内质网(ER)伴侣蛋白上调。凋亡归因于钙漏和 PERK 和 IRE1α 磷酸化的共同作用。PERK 分支负责在 24 小时内发生的第一波细胞死亡。后期的凋亡由 IRE1α介导,通过 ASK-JNK-BIM 轴传递凋亡信号。内质网中 Ca2+释放到细胞质中导致钙蛋白酶的激活,反过来又使半胱天冬酶-12 裂解。我们的数据还解释了 Oprozomib 对 CML 细胞的选择性杀伤作用,这依赖于蛋白酶体活性。本研究表明,延长蛋白酶体抑制以引发未折叠蛋白反应可能是治疗 CML 的一种替代策略,鉴于酪氨酸激酶抑制剂耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7999/7780017/aa06e470c2b5/CAS-112-133-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验